You’ve probably heard it said before; the only screening tool that has the power to detect and prevent colorectal cancer (CRC) is colonoscopy—not FIT tests, not CT colonoscopy, and not stool DNA tests. While other methods might seem easier or less intimidating, they simply do not deliver the benefits of colonoscopy, that is, the ability to find and remove polyps.
According to the American College of Gastroenterologists (ACG), adenoma detection rate (ADR) is “the measurement that best reflects how carefully colonoscopy is performed.“ Defined as the percentage of patients age 50 and older undergoing screening colonoscopy who have one or more precancerous polyps detected, ADR is calculated by dividing the number of procedures in which one or more adenomas is detected by the total number of procedures. An endoscopist’s ADR should be at least 25% for men and 15% for women.
A recently published study in Journal of Gastroenterology and Hepatology Research found that use of ColoWrap significantly enhanced adenoma detection in obese patients, females, and patients 60 and older. In addition, ColoWrap was associated with increased polyp and sessile serrated polyp (SSP) detection in the cecum and ascending colon across all patients in the study. These findings provide substantial additional support for the utility of ColoWrap as a tool to improve colonoscopy quality, particularly for patients at-risk for a difficult colonoscopy due to a tortuous, redundant colon or body habitus.